Immunovant (IMVT) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Immunovant, Inc. is optimizing global antibody supply chains through a network of cold-storage warehouses to preserve margins. High growth potential is based on unique intellectual property in the treatment of autoimmune pathologies. The asset's value depends exclusively on clinical trial results. The change in the EV/EBITDA ratio over time demonstrates the fundamental value of the business, where 0.00 represents the current level of the metric.
immunovant.com - analytical breakdowns and key metrics (IMVT)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
IMVT - Net Income|Future Profit Immunovant, Inc.|IMVT - P/E Multiple|Future Price to Earnings Immunovant, Inc.|IMVT - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunovant Therapeutics|IMVT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Immunovant|IMVT - Earnings per share for the last twelve months|Quarterly EPS earnings growth immunovant.com|IMVT - Earnings growth in current year|Net earnings per share growth forecast for next year Immunovant, Inc.
Initial company analysis:Immunovant Corp IMVT
This ratio compares the total enterprise value of the business with its operating profit before depreciation and amortization, allowing for an assessment of the actual debt load and cash flow generation efficiency. Analyzing the EV/EBITDA metric of Immunovant, Inc. (IMVT) within a historical context helps determine the capital stability of Immunovant, Inc. in the face of regulatory barriers and high risks associated with the clinical trial results of its key drug.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kiniksa Pharmaceuticals, Ltd.|Enterprise Value to EBITDA Ratio GRFS|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Pharvaris Pharma PHVS|abcellera.com (ABCL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio tourmalinebio.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Precigen|Enterprise Value to EBITDA Ratio Pharming Group NV (PHAR)|Enterprise Value to EBITDA Ratio NKTR (Nektar)|EV/EBITDA Multiple Upstream Pharma (UPB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zenas Biopharma Inc ZBIO|IMNM: Enterprise Value to Operating Income Before Depreciation|GOSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA KalVista Pharma|SEPN (Septerna Corp) - Enterprise Value to EBITDA Ratio|PVLA (Pieris Corp) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SVRA (Savara Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple rigel.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio (ANAB)|Astria Therapeutics Inc - Enterprise Value to Operating Income Before Depreciation|enGene Bio - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio RAPT (rapt.com)|JBIO: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ACRS (aclaristx.com)|KYTX: EV/EBITDA Multiple|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cabaletta Bio, Inc|Enterprise Value to Operating Income Before Depreciation VTYX (Ventyx Biosciences, Inc)|EV/EBITDA Multiple THTX|Enterprise Value to EBITDA Ratio avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Agenus, Inc. (AGEN)|Climb Bio, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio zurabio.com ZURA|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Adagene Inc.|Enterprise Value to EBITDA Ratio IMA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STTK|Enterprise Value to EBITDA Ratio EQ (Equillium, Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio CNTB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Value to Operating Income Before Depreciation Ratio|InflaRx GmbH - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|ACET: EV/EBITDA Multiple|Celularity (CELU) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|BRNS: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation GOVX (geovax.com)|EDSA: EV/EBITDA Multiple|IBIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carisma Therapeutics Inc|Enterprise Value to EBITDA Ratio XTL Bio (XTLB)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Enterprise Value to EBITDA Ratio hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple aimimmuno.com AIM|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI (GRI Bio Corporation) - Enterprise Value to Operating Income Before Depreciation|XRTX: EV/EBITDA Multiple|Company Value to EBITDA reshapelifesciences.com (HIND)|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Indaptus Therapeutics Inc (INDP) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|Enterprise Value to EBITDA Ratio calcimedica.com CALI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Affimed N.V. AFMD|ALLK - Enterprise Value to EBITDA Ratio|HOOK: Enterprise Value to EBITDA Ratio|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation OCEA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Company Value to EBITDA thirdharmonicbio.com THRD
